Needham & Company Lifts PT on Cree (CREE) on 'Strong' Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- eToro to acquire TradeZero for up to $231M to expand in US
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Canaccord Genuity Boosts Cree (CREE) PT to $37
January 23, 2013 8:47 AM ESTCanaccord Genuity raised its price target on Cree (NASDAQ: CREE) from $32 to $37 but kept a Hold rating following Q2 results.
The firm comments, "We maintain our HOLD rating on CREE shares as we see improvement in the LED macro and multiple expansion in... More
Piper Jaffray Assumes Cree (CREE) at Overweight
January 23, 2013 7:56 AM ESTPiper Jaffray assumes coverage on Cree (NASDAQ: CREE) with a Overweight. PT $43.00.
For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.
Shares of Cree closed at $33.47 yesterday, with a 52 week range of $22.25-$35.09.... More
Cree, Inc. (CREE) Tops Q2 EPS by 2c; Guides Q3 EPS, Revs Above
January 22, 2013 4:01 PM ESTCree, Inc. (NASDAQ: CREE) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $346.3 million versus the consensus estimate of $331.2 million.
Cree, Inc. sees Q3 2013 EPS of $0.30-0.35, versus the consensus of $0.28. Cree, Inc. sees Q3 2013... More
